We've found
9,144
archived clinical trials in
Ocular
We've found
9,144
archived clinical trials in
Ocular
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Click here to add this to my saved trials
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Click here to add this to my saved trials
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Click here to add this to my saved trials
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Click here to add this to my saved trials
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Click here to add this to my saved trials
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Click here to add this to my saved trials
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Click here to add this to my saved trials
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Investigation of the Presbia Flexivue Microlens™
Updated: 9/10/2015
Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes
Status: Enrolling
Updated: 9/10/2015
Click here to add this to my saved trials
Patient Perception of Visual Quality and Function
Status: Enrolling
Updated: 9/10/2015
Updated: 9/10/2015
Patient Perception of Visual Quality and Function
Status: Enrolling
Updated: 9/10/2015
Updated: 9/10/2015
Click here to add this to my saved trials
FST-100 in the Treatment of Acute Viral Conjunctivitis
Updated: 9/14/2015
A Multi-Center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Viral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
FST-100 in the Treatment of Acute Viral Conjunctivitis
Updated: 9/14/2015
A Multi-Center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Viral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Click here to add this to my saved trials
FST-100 in the Treatment of Acute Viral Conjunctivitis
Updated: 9/14/2015
A Multi-Center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Viral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
FST-100 in the Treatment of Acute Viral Conjunctivitis
Updated: 9/14/2015
A Multi-Center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Viral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Click here to add this to my saved trials
Improving Function in Age-Related Macular Degeneration
Updated: 9/14/2015
Improving Function in Age-Related Macular Degeneration
Status: Enrolling
Updated: 9/14/2015
Improving Function in Age-Related Macular Degeneration
Updated: 9/14/2015
Improving Function in Age-Related Macular Degeneration
Status: Enrolling
Updated: 9/14/2015
Click here to add this to my saved trials
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
Click here to add this to my saved trials
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
Click here to add this to my saved trials
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
Click here to add this to my saved trials
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
Click here to add this to my saved trials
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
Click here to add this to my saved trials
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
Click here to add this to my saved trials
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
Click here to add this to my saved trials
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
Click here to add this to my saved trials
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
Click here to add this to my saved trials
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
Click here to add this to my saved trials
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
Click here to add this to my saved trials
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
Click here to add this to my saved trials
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis
Status: Enrolling
Updated: 9/14/2015
Updated: 9/14/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD
Updated: 9/15/2015
Phase 2a, Multicenter, Masked, Randomized, Comparator Controlled Study Evaluating iSONEP™ as Monotherapy or Adjunctive Therapy to Lucentis/Avastin/Eylea Versus Lucentis/Avastin/Eylea Alone for Treatment of Subjects With CNV Secondary to AMD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials